课题基金 / 基金详情

项目摘要

项目成果

KENNETH M. MERZ的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Our long-term goal is to enhance our understanding of metalloprotein structure, function and inhibition. The tools we will use are those of theoretical, computational and medicinal chemistry. The long-term goal of the present proposal is to use these techniques to understand the structure, function and inhibition of the family of zinc (and magnesium) dependent sulfur alkylation enzymes called protein prenyltransferases. In particular, we will be study farnesyltransferase (FTase) and geranylgeranyltransferase type I (GGTase) using quantum mechanical (QM), QM/molecular mechanical (MM), molecular dynamics simulations, QM based X- ray refinement and docking/scoring studies. The overarching biological question we are addressing is the catalytic mechanism of zinc catalyzed protein prenylation and how this process can be inhibited to generate compounds relevant to cancer treatment, as well as other diseases. To reach this important biological goal we propose to study small molecule/enzyme interactions and the mechanism of these zinc catalyzed enzyme reactions using our theoretical tools. In order to enhance the quality of our computational efforts we are collaborating with experimentalists who are expert in the structure, function and inhibition of FTase and GGTase. Our experimental collaborators will assist in QM/MM based X-ray refinement studies, will generate mutant enzymes based on our computational observation in order to test our models, will carry out binding assays on novel small molecule inhibitors we identify and purchase and will synthesize novel compounds we propose. With the successful completion of the proposed project we will have generated mechanistic insights that will be translated into the design of novel inhibitors of FTase and GGTase that can be tested as treatment for human cancer.
期刊论文(27)
专著(0)
科研奖励(0)
会议论文
Conformational analysis and parallel QM/MM X-ray refinement of protein bound anti-Alzheimer drug donepezil.
蛋白结合的抗alzheimer药物多奈替齐的构象分析和平行QM/MM X射线细化。
DOI: 10.1021/ct300957x
发表时间: 2013-12-03
期刊: JOURNAL OF CHEMICAL THEORY AND COMPUTATION
影响因子: 5.5
作者: [Fu, Zheng, Li, Xue, Miao, Yipu, Merz, Kenneth M., Jr.]
通讯作者: Merz, Kenneth M., Jr.
DOI: 10.1021/jp505875v
发表时间: 2015-01-22
期刊: The journal of physical chemistry. B
影响因子: --
作者: [Li P, Song LF, Merz KM Jr]
通讯作者: Merz KM Jr
DOI: 10.1021/ct100102q
发表时间: 2010
期刊: JOURNAL OF CHEMICAL THEORY AND COMPUTATION
影响因子: 5.5
作者: [Merz, Kenneth M., Jr.]
通讯作者: Merz, Kenneth M., Jr.
DOI: 10.1021/ct400856g
发表时间: 2013-12-10
期刊: JOURNAL OF CHEMICAL THEORY AND COMPUTATION
影响因子: 5.5
作者: [Weaver, Michael N., Merz, Kenneth M., Jr., Ma, Dongxia, Kim, Hyun Jung, Gagliardi, Laura]
通讯作者: Gagliardi, Laura
21
    The Bioinorgainic Chemistry and Nickel: The Ureases and NikR
    • 批准号:
      7937591
    • 项目类别:
    • 资助金额:
      $7.5万
    • 财政年份:
      2009
    • 负责人:
      KENNETH M. MERZ
    • 依托单位:
    Enhancement and Deployment of the Quantum Mechanical NMR Pose Scoring Method
    • 批准号:
      7327341
    • 项目类别:
    • 资助金额:
      $43.38万
    • 财政年份:
      2006
    • 负责人:
      KENNETH M. MERZ
    • 依托单位:
    Enhancement and Deployment of the Quantum Mechanical NMR Pose Scoring Method
    • 批准号:
      7383869
    • 项目类别:
    • 资助金额:
      $44.53万
    • 财政年份:
      2006
    • 负责人:
      KENNETH M. MERZ
    • 依托单位:
    Enhancement and Deployment of the Quantum Mechanical NMR Pose Scoring Method
    • 批准号:
      7155296
    • 项目类别:
    • 资助金额:
      $9.93万
    • 财政年份:
      2006
    • 负责人:
      KENNETH M. MERZ
    • 依托单位:
    海外基金